We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.41B
AUM Growth
+$125M
Cap. Flow
-$6.29M
Cap. Flow %
-0.45%
Top 10 Hldgs %
35.33%
Holding
276
New
13
Increased
51
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
CLF icon
Cleveland-Cliffs
CLF
+$3.71M
2
XOM icon
ExxonMobil
XOM
+$2.57M
3
PANW icon
Palo Alto Networks
PANW
+$1.41M
4
NVO
Novo Nordisk
NVO
+$1.2M
5
URI icon
United Rentals
URI
+$909K

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$3.95M
2
VZ icon
Verizon
VZ
+$2.07M
3
NEE icon
NextEra Energy
NEE
+$1.38M
4
INTC icon
Intel
INTC
+$1.28M
5
IBM icon
IBM
IBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 19.24%
3 Financials 13.15%
4 Industrials 11.27%
5 Communication Services 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSX icon
101
Phillips 66
PSX
$81.4B
$1.55M 0.11%
21,372
– –
MOG.A icon
102
Moog Inc Class A
MOG.A
$12.8B
$1.53M 0.11%
18,956
– –
CARR icon
103
Carrier Global
CARR
$52.8B
$1.52M 0.11%
28,003
-135
-0.5% -$7.29K
PANW icon
104
Palo Alto Networks
PANW
$297B
$1.52M 0.11%
+16,350
New +$1.41M
MDT icon
105
Medtronic
MDT
$112B
$1.51M 0.11%
14,579
-100
-0.7% -$11.6K
MRSH
106
Marsh
MRSH
$91.5B
$1.48M 0.11%
8,530
– –
ROK icon
107
Rockwell Automation
ROK
$49B
$1.43M 0.1%
4,100
– –
AVGO icon
108
Broadcom
AVGO
$2.04T
$1.34M 0.1%
20,150
+10,000
+99% +$562K
DD icon
109
DuPont de Nemours
DD
$19.2B
$1.33M 0.09%
13,151
-239
-2% -$22.7K
GILD icon
110
Gilead Sciences
GILD
$165B
$1.32M 0.09%
18,254
-100
-0.5% -$6.89K
CNI icon
111
Canadian National Railway
CNI
$76.6B
$1.3M 0.09%
10,602
– –
A icon
112
Agilent Technologies
A
$41.2B
$1.3M 0.09%
8,128
– –
WMT icon
113
Walmart Inc
WMT
$890B
$1.29M 0.09%
26,823
– –
DUK icon
114
Duke Energy
DUK
$97.3B
$1.29M 0.09%
12,294
-1,075
-8% -$109K
GAM
115
General American Investors Company
GAM
$1.61B
$1.29M 0.09%
29,180
– –
WY icon
116
Weyerhaeuser
WY
$18.4B
$1.26M 0.09%
30,600
– –
CI icon
117
Cigna
CI
$74.6B
$1.25M 0.09%
5,431
-518
-9% -$110K
NVO
118
Novo Nordisk
NVO
$209B
$1.24M 0.09%
+22,090
New +$1.2M
GE icon
119
GE Aerospace
GE
$384B
$1.23M 0.09%
20,937
-139
-0.7% -$8.73K
KMB icon
120
Kimberly-Clark
KMB
$36.5B
$1.21M 0.09%
8,495
– –
MKC icon
121
McCormick & Company Non-Voting
MKC
$14.2B
$1.21M 0.09%
12,500
-1,700
-12% -$145K
TROW icon
122
T. Rowe Price
TROW
$24.3B
$1.2M 0.08%
6,075
– –
URI icon
123
United Rentals
URI
$72.4B
$1.19M 0.08%
3,565
+2,550
+251% +$909K
USB icon
124
US Bancorp
USB
$99.6B
$1.18M 0.08%
20,976
– –
XLI icon
125
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
$1.16M 0.08%
10,990
-630
-5% -$65.4K
3 4
5
6 7

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, Neville Rodie & Shaw held 276 positions worth $1.41B, up 9.7% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q4 2021 filing shows 13 new, 51 increased, 96 reduced and 8 closed positions. Its largest new stake was Cleveland-Cliffs: 172,300 shares worth $3.75M. The largest sale was Acceleron Pharma, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q4 2021 buy was Cleveland-Cliffs: 172,300 shares worth $3.75M.
  • Neville Rodie & Shaw added most to ExxonMobil in Q4 2021, an estimated $2.57M increase.
  • Neville Rodie & Shaw's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.07M.
  • Neville Rodie & Shaw fully exited Acceleron Pharma in Q4 2021, selling an estimated $3.95M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.41B portfolio in Q4 2021.
  • Neville Rodie & Shaw opened 13 new positions and closed 8 in Q4 2021.
  • Neville Rodie & Shaw's portfolio value rose 9.7% quarter-over-quarter to $1.41B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2021, filed 5 Jan 2022.